Cargando…
SRGAP2a: A New Player That Modulates Podocyte Cytoskeleton and Injury in Diabetes
Autores principales: | Levi, Moshe, Myakala, Komuraiah, Wang, Xiaoxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860859/ https://www.ncbi.nlm.nih.gov/pubmed/29559512 http://dx.doi.org/10.2337/dbi17-0050 |
Ejemplares similares
-
Impact of klotho on the expression of SRGAP2a in podocytes in diabetic nephropathy
por: Jin, Donghua, et al.
Publicado: (2022) -
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice
por: Wang, Dong, et al.
Publicado: (2018) -
The human-specific paralogs SRGAP2B and SRGAP2C differentially modulate SRGAP2A-dependent synaptic development
por: Schmidt, Ewoud R. E., et al.
Publicado: (2019) -
Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
por: Wang, Dong, et al.
Publicado: (2017) -
Human glomerular transcriptome of diabetic kidneys: Can the podocyte cytoskeleton be a therapeutic target?
por: Maezawa, Yoshiro, et al.
Publicado: (2018)